Page last updated: 2024-08-23

pravastatin and Disease Models, Animal

pravastatin has been researched along with Disease Models, Animal in 137 studies

Research

Studies (137)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's10 (7.30)18.2507
2000's54 (39.42)29.6817
2010's59 (43.07)24.3611
2020's14 (10.22)2.80

Authors

AuthorsStudies
Hori, S; Kikkawa, T; Mori, S; Ohtsuki, S; Otagiri, M; Takanaga, H; Terasaki, T1
Askew, V; Auerbach, B; Dillon, L; Hanselman, JC; Kennedy, RM; Kowala, MC; Larsen, SD; Lin, Z; Lu, GH; Miller, S; Park, WK; Robertson, A; Roth, BD; Sekerke, C; Song, Y; Steinbaugh, BA; Sun, K; Tait, BD; Trivedi, BK1
Bienvenu, AL; Picot, S1
Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV1
Cao, LP; Li, L; Nie, SN; Ren, Y; Sun, ZR; Wang, MM; Yang, ZZ; Zhang, P; Zhang, W1
Chen, ZL; Deng, F; Hu, JJ; Li, C; Lin, ZB; Liu, KX; Liu, WF; Liu, Y; Luo, SD; Sun, QS; Yan, ZZ; Yang, X; Yao, ZW; Zhao, BC1
Cho, SS; Jang, H; Jang, WI; Kim, MJ; Kwak, SY; Lee, SB; Park, S; Shim, S1
Clifton, RG; Costantine, MM; Saade, GR1
Adams, LC; Botnar, RM; Brangsch, J; Hamm, B; Kaufmann, JO; Makowski, MR; Onthank, DC; Reimann, C; Robinson, SP; Thöne-Reineke, C1
Birukov, A; Dechend, R; Geisberger, S; Golic, M; Haase, N; Herse, F; Heuser, A; Kräker, K; Müller, DN; O'Driscoll, JM; Patey, O; Schütte, T; Thilaganathan, B; Verlohren, S1
Cherrington, NJ; Clarke, JD; Csanaky, IL; Toth, EL1
Abd Allah, EF; Charan, J; Hashem, A; Jaipal, N; Kashyap, P; Kumar, S; Ram, H; Siddaiah, CN; Singh, BP; Tabassum, B; Tripathi, R1
Jang, H; Jang, WS; Kim, H; Kim, K; Kim, MJ; Kim, YH; Kwak, SY; Lee, SJ; Myung, JK; Na, J; Park, S; Shim, S1
Adam, N; Al-Rewashdy, H; Bronicki, LM; Coriati, A; Holcik, M; Jasmin, BJ; Mears, A; Péladeau, C; Renaud, JM; Thabet, M; Vanstone, J1
Cabral, WA; Collins, FS; Cubria, MB; DuBose, A; Erdos, MR; Kamalapathy, P; Karim, L; Masoudi, A; Nazarian, A; Oftadeh, R; Snyder, BD; Suarez, S1
Chen, Y; Hu, L; Jia, J; Liu, X; Luo, X; Ou, Y; Shen, W; Shi, H; Sun, S; Zhang, H; Zhou, G1
Andia, ME; Botnar, RM; Lavin Plaza, B; Lorrio, S; Phinikaridou, A; Potter, M; Rashid, I1
Abeydeera, D; Demer, LL; Fong, F; Iriana, S; Lu, M; Patel, NR; Qiao, R; Tintut, Y; Xian, JZ1
Girardi, G1
Alijotas-Reig, J; Baraldès-Farré, A; Esteve-Valverde, E; Ferrer-Oliveras, R; Gil-Aliberas, N; Llurba, E1
Chen, J; Li, H; Li, N; Liu, C; Sun, J; Wang, C1
Huai, J; Wang, GJ; Yang, Z; Yi, YH1
Beck, B; Donner, D; du Toit, EF; Headrick, JP; Oi, M; Peart, J; Wendt, L1
Hur, J; Kang, JY; Kim, YK; Lee, SY; Liang, L; Rhee, CK1
Clark, JE; Garrett, N; Girardi, G; Pombo, J; Simmons, M; Umpierrez, M1
Li, Q; Xiao, S; Zhang, X1
Gao, JH; Lu, JL; Wang, HM1
Chimini, JS; da Silva, MLS; Dias-Junior, CA; Possomato-Vieira, JS1
Heo, TH; Park, KY1
Cho, O; Heo, TH; Kim, HS; Park, KY1
Banek, CT; Bauer, AJ; Capoccia, S; Gilbert, JS; Gillham, H; Needham, K; Regal, JF1
Fukumoto, Y; Kudo, S; Liao, JK; Minami, T; Nochioka, K; Shiba, N; Shimokawa, H; Takai, Y; Tanaka, S; Williams, CL1
Costantine, MM; Hankins, GD; Kechichian, T; Longo, M; Saad, AF; Saade, GR; Sbrana, E; Tamayo, E; Wen, M; Yin, H1
Albano, A; Aronovitz, M; Galper, JB; Jin, H; Link, MS; Noujaim, SF; Park, HJ; Rajab, M; Welzig, CM; Zhang, Y1
Carver, AR; Costantine, MM; Hankins, GD; Perez-Polo, JR; Saade, GR; Tamayo, E1
Costantine, MM; Gamble, P; Hankins, GD; Kechichian, T; Longo, M; McDonnold, M; Saade, GR; Tamayo, E1
Chen, W; Jiang, Y; Li, P; Lin, N; Lu, C; Xu, Y; Zhang, H; Zhang, Y; Zhu, B1
Brem, H; Huang, Y; Hwang, L; Jallo, G; Kang, JU; Pradilla, G; Ruzevick, J; Suk, I; Tyler, BM; Wicks, RT; Zhang, K; Zhao, M1
Aktaş, SG; Atay, A; Çuhadar, S; Dursun, S; Köseoğlu, M1
Andrikopoulou, M; Burd, I; Carver, AR; Costantine, MM; Gamble, P; Hou, Z; Lei, J; Mori, S; Saade, GR; Tamayo, E; Zhang, J1
Adamicová, K; Adamkov, M; Bojková, B; Chmelová, M; Kajo, K; Kapinová, A; Kassayová, M; Kružliak, P; Kubatka, P; Orendáš, P; Péč, M; Sadloňová, V; Stollárová, N; Výbohová, D1
Fledderus, JO; Giles, RH; Gremmels, H; Joles, JA; Oosterhuis, NR; Papazova, DA; van Koppen, A; Verhaar, MC1
Li, F; Ling, Z; Liu, C; Liu, L; Liu, X; Shu, N; Xu, D; Zhang, M; Zhong, Z1
Ikeda, S; Kikuchi, N; Kudo, S; Kurosawa, R; Minami, T; Miyata, S; Nogi, M; Omura, J; Satoh, K; Satoh, T; Shimokawa, H; Sunamura, S; Suzuki, K1
Clark, SM; Costantine, MM; Diken, ZM; Kechichian, TB; Olson, GL; Saad, AF; Saade, GR1
Chen, Y; Dong, B; Guo, T; Li, P; Liang, WJ; Liu, C; Ma, H; Pang, XY; Shan, MR; Wang, SX; Wang, XQ; Wang, YL; Yin, YL; Yu, HY; Zhou, SN1
Gruenbaum, Y; Meshorer, E1
Haslinger-Löffler, B1
Demachi, J; Fukumoto, Y; Ishii, N; Kagaya, Y; Karibe, A; Nakano, M; Nawata, J; Satoh, K; Shimokawa, H; Sugamura, K; Sugimura, K1
Canty, JM; Cimato, T; Iyer, V; Suzuki, G1
Fang, HY; Wu, SY1
Satoh, A; Satoh, M1
Baudelin, C; Benderitter, M; Buard, V; Gaugler, MH; Guipaud, O; Holler, V; Milliat, F; Perez, Mdel R; Sache, A; Squiban, C; Tamarat, R1
Girardi, G; Redecha, P; Torry, D; van Rooijen, N1
Anantharamaiah, GM; Cao, D; Garber, DW; Handattu, SP; Kadish, I; Li, L; Monroe, CE; Nayyar, G; Palgunachari, MN; van Groen, T1
Ito, R; Ito, Y; Itoh, T; Kajikuri, J; Watanabe, Y; Yamamoto, T1
Brahmachari, S; Gendelman, HE; Ghosh, A; Matras, J; Pahan, K; Roy, A1
Bang, YJ; Byun, HJ; Kim, W; Lee, HS; Lee, SH; Lee, SM; Myung, SJ; Yang, JI; Yoon, JH1
de Hoz, R; Mendez, T; Ramírez, AI; Ramírez, JM; Raposo, R; Redondo, A; Rojas, B; Salazar, JJ; Tejerina, T; Triviño, A1
Eldawoody, H; Kimura, N; Nakayama, T; Saito, A; Shimizu, H; Takahashi, A; Tominaga, T1
Ezaki, K; Hara, M; Nagano-Torigoe, Y; Nakagawa, M; Saikawa, T; Takahashi, N; Teshima, Y; Thuc, LC; Yufu, K1
Chen, CC; Hsu, YJ; Lee, TM; Lien, HY; Lin, CC; Shih, CM1
Castellani, LW; Fogelman, AM; Iikuni, N; La Cava, A; Li, H; Lin, Z; Lusis, AJ; Navab, M; Rullo, OJ; Trejo-Lopez, Y; Tsao, BP; Van Dyck, C; Wang, X; Woo, JM; Woo, KM; Wu, H1
Arruda, AP; Breder, I; Coope, A; de Oliveira, HC; Dorighello, Gde G; Milanski, M; Razolli, D; Velloso, LA1
Ando, K; Inoue, N; Ishibashi, T; Kamioka, M; Kaneshiro, T; Maruyama, Y; Ohkawara, H; Saitoh, S; Sugimoto, K; Takeishi, Y; Takuwa, Y; Uekita, H1
Kim, JW; Kim, KH; Kim, SC; Kim, TJ; Kim, YH; Kim, YK; Kwon, SS; Lee, SH; Lee, SY; Rhee, CK; Yoon, HK1
Chang, CC; Huang, HC; Lee, FY; Lee, JY; Lee, SD; Lin, HC; Wang, SS1
Ahmed, A; Girardi, G; Khan, Y; Seshan, SV; Singh, J1
Kückelhaus, CS; Kückelhaus, SA; Muniz-Junqueira, MI1
Hasuwa, H; Ikawa, M; Kidoya, H; Kimura, T; Kumasawa, K; Morioka, Y; Okabe, M; Saito-Fujita, T; Takakura, N1
Aubuchon, M; Schulz, LC; Schust, DJ1
Brcakova, E; Cermanova, J; Fuksa, L; Hirsova, P; Hyspler, R; Kolouchova, G; Lotkova, H; Micuda, S; Sispera, L; Slanarova, M; Tomsik, P1
Kageji, T; Kanematsu, Y; Kinouchi, T; Kitazato, KT; Matsushita, N; Nagahiro, S; Satomi, J; Shimada, K; Tada, Y; Yagi, K1
Biasibetti, R; Bobermin, L; Gonçalves, CA; Quincozes-Santos, A; Rodrigues, L; Tramontina, AC; Tramontina, F; Wartchow, KM1
Chan, CY; Chang, CC; Chuang, CL; Hsin, IF; Huang, HC; Lee, FY; Lee, SD; Lin, HC; Teng, TH; Wang, SS1
Ahmed, A; Girardi, G; Singh, J1
Black, A; Byrne, J; Dietz, HC; Hill, AD; Huuskonen, V; Kay, E; Kearney, S; McAllister, H; McGuinness, J; McLoughlin, D; Redmond, JM; Terzo, E1
Brcakova, E; Cermanova, J; Fuksa, L; Hirsova, P; Kolouchova, G; Lastuvkova, H; Micuda, S; Mokry, J; Nachtigal, P1
Ishii, Y; Izumikawa, K; Kimura, S; Kohno, S; Ohno, A; Saga, T; Tashiro, M; Tashiro, T; Tateda, K; Yamaguchi, K1
Bytautiene, E; Costantine, MM; Fox, KA; Hankins, GD; Kechichian, T; Longo, M; Saade, GR; Tamayo, E1
Hong, SJ; Kim, PS; Ko, JH; Mustoe, TA; Zhao, Y1
Kumagai, K; Miyata, N; Niwa, M; Nozaki, Y1
Anastasiou-Nana, M; Andreadou, I; Farmakis, D; Iliodromitis, EK; Kremastinos, DT; Papalois, A; Papapetropoulos, A; Prokovas, E; Sigala, F; Spyridaki, K; Zoga, A1
Kamata, K; Kobayashi, T; Matsumoto, T; Nemoto, S; Taguchi, K1
Basraon, SK; Costantine, MM; Hankins, GD; Longo, M; Makhlouf, M; Menon, R; Saade, GR1
Huang, C; Huang, Z; Jiang, H; Wu, G; Xie, Q; Xu, L1
Kang, HH; Kim, IK; Kim, JW; Kim, KH; Kim, YK; Kwon, SS; Lee, SH; Lee, SY; Rhee, CK; Yeo, CD1
Alexander, JS; Bharwani, S; Carter, P; Elrod, JW; Grisham, MB; Harada, H; Joh, T; Jordan, P; Manas, K; Sasaki, M; Warren, A; Wolcott, M1
Ichihara, K; Kanda, M; Satoh, K1
Blum, HE; Spangenberg, HC; Thimme, R; Von Weizsäcker, F; Zuber-Jerger, I1
Domínguez, J; Schultz, M1
Aiso, M; Akashi, M; Kurihara, H; Sano, N; Sasamoto, T; Tachizawa, H; Takada, Y; Takamori, Y; Takayanagi, M; Takikawa, H1
Chen, Y; Kiyomoto, H; Kohno, M; Mizushige, K; Ohmori, K; Sato, C; Shinomiya, K; Takeuchi, H; Yu, Y1
Chang, NC; Chou, TF; Lee, TM; Lin, MS; Tsai, CH1
Kakinuma, C; Kuwayama, C; Naba, H; Ogihara, T; Ohnishi, S1
Bouchier-Hayes, D; Casey, RG; Chen, G; Joyce, M; Roche-Nagle, G1
Cha, JH; Kang, DH; Kang, SW; Kim, J; Kim, YS; Li, C; Lim, SW; Song, JC; Sun, BK; Yang, CW1
Caracchini, R; Colucci, M; Giannini, S; Gresele, P; Guglielmini, G; Momi, S; Monopoli, A; Ongini, E; Rossiello, MR; Semeraro, N1
Banno, H; Fujita, H; Kobayashi, M; Komori, K; Kuwano, H; Nakayama, M; Sugimoto, M; Yamanouchi, D1
Kakinuma, C; Naba, H; Ogihara, T; Ohnishi, S1
Feng, JH; Kang, MF; Li, YQ; Ma, LP; Nie, DN; Wu, YD; Xie, SF; Xu, LZ; Yin, SM1
Chen, C; Ran, ZH; Xiao, SD1
Dichgans, M; Hamann, GF; Trinkl, A; Vosko, MR; Wunderlich, N1
Abolhassani, F; Ebrahimnejad, M; Jahanzad, I; Nouri, M; Pourabbasi, A1
Clements, JD; Jamali, F1
Funauchi, M; Ikoma, S; Kinoshita, K; Nozaki, Y; Sugiyama, M; Yamagata, T1
Dong, YF; Kataoka, K; Kim-Mitsuyama, S; Lai, ZF; Matsuba, S; Ogawa, H; Tanaka, T; Tokutomi, Y; Yamamoto, E; Yamashita, T1
Chen, Y; Kohno, M; Kosaka, H; Mizukawa, M; Ohmori, K; Shinomiya, K; Yoshida, J; Zeng, Y; Zhang, L1
Arakawa, E; Hasegawa, K; Ina, Y; Matsubara, M; Takada, C; Takayama, M; Yao, K1
Abe, M; Caslake, MJ; Fukuhara, A; Funahashi, T; Kihara, S; Kobayashi, H; Komuro, R; Matsuda, M; McMahon, A; Shepherd, J; Shimomura, I; Takagi, T1
Arakawa, T; Fujiwara, Y; Higuchi, K; Oshitani, N; Shiba, M; Taira, K; Takeuchi, K; Tanigawa, T; Tominaga, K; Watanabe, T; Yamato, M1
Chen, B; Zheng, Z1
Chang, NC; Lee, TM; Lin, MS1
Arai, M; Bao, N; Fujiwara, H; Fujiwara, T; Iwasa, M; Kawamura, I; Kobayashi, H; Minatoguchi, S; Misao, Y; Nishigaki, K; Sumi, S; Takemura, G; Yamaki, T; Yasuda, S1
Fujioka, D; Kawabata, K; Kitta, Y; Kobayashi, T; Kodama, Y; Kugiyama, K; Nakamura, T; Obata, JE; Saito, Y; Takano, H; Yano, T1
Hori, M; Kitagawa, K; Ohyama, N; Sasaki, T; Sugiura, S; Terasaki, Y; Todo, K; Yagita, Y1
Crockett, JC; Hughes, A; Idris, AI; Rogers, MJ1
Chiba, M; Hirano, T; Iseki, K; Itagaki, S; Kobayashi, M1
Akino, M; Matsui, Y; Okamoto, H; Onozuka, H; Tsutsui, H; Xu, Z1
Kita, T; Otani, H; Tanaka, M; Yokode, M1
Fujioka, T; Fukami, M; Fukushige, J; Nara, F; Shigehara, E; Shimada, Y; Shimotsu, H; Tsujita, Y1
Albarrán, OG; García-Robles, R; Rábano, A; Ruilope, LM; Villa, E1
Dai, E; Liu, LY; Lucas, A; Nation, PN1
Horikoshi, H; Ito, T; Shiomi, M; Tsujita, Y; Tsukada, T1
Asanuma, H; Hori, M; Kitakaze, M; Komamura, K; Kuzuya, T; Minamino, T; Sato, H; Takeda, H; Ueda, Y1
Gross, W; März, W; Müller, HM; Olbrich, HG; Siekmeier, R; Wieland, H1
Ando, A; Hori, M; Horio, M; Imai, E; Kawada, N; Moriyama, T; Nagatoya, K; Takeji, M1
Brinkmann, V; Bruns, C; Cottens, S; Hommel, U; Kallen, J; Kamata, T; Takada, Y; Weitz-Schmidt, G; Welzenbach, K1
Cittadino, M; Coelho, OR; Coelho-Filho, OR; De Luca, IM; Hyslop, S; Moreno Júnior, H; Sampaio, RC; Tanus-Santos, JE1
Egashira, K; Inoue, S; Kataoka, C; Kitamoto, S; Koyanagi, M; Ni, W; Takeshita, A1
Enomoto, M; Hirouchi, Y; Ito, T; Shiomi, M1
Kakuta, H; Moritani, H; Shikama, H; Ugawa, T1
Aoyagi, S; Fujii, T; Hiromoto, M; Itoh, S; Matsuzaki, M; Tanaka, M; Toma, Y; Tomochika, Y; Umemoto, S1
Aihara, N; Hatsushika, S; Kajiyama, G; Mizuno, S; Sagawa, H; Sasaki, H; Sasaki, M; Tao, S; Tazuma, S; Yamashita, G1
Arbeeny, CM; Bergquist, KE1
Aihara, N; Hatsushika, S; Mizuno, S; Oya, T; Sagawa, H; Sasaki, H; Sasaki, M; Tazuma, S; Toge, S; Yamashita, G1
Arai, H; Ishii, K; Kawai, C; Kita, T; Kume, N; Nagano, Y; Otani, H; Ueda, Y; Yokode, M1

Reviews

3 review(s) available for pravastatin and Disease Models, Animal

ArticleYear
Pravastatin to treat and prevent preeclampsia. Preclinical and clinical studies.
    Journal of reproductive immunology, 2017, Volume: 124

    Topics: Animals; Anticholesteremic Agents; Clinical Trials as Topic; Disease Models, Animal; Drug Evaluation, Preclinical; Female; Fetal Development; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mice; Placenta; Pravastatin; Pre-Eclampsia; Pregnancy

2017
Pravastatin for Preventing and Treating Preeclampsia: A Systematic Review.
    Obstetrical & gynecological survey, 2018, Volume: 73, Issue:1

    Topics: Animals; Disease Models, Animal; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Placenta; Placentation; Pravastatin; Pre-Eclampsia; Pregnancy; Randomized Controlled Trials as Topic; Severity of Illness Index

2018
[Systemic treatment for hepatocellular carcinoma].
    Zentralblatt fur Chirurgie, 2003, Volume: 128, Issue:11

    Topics: Adjuvants, Immunologic; Angiogenesis Inhibitors; Animals; Antibiotics, Antineoplastic; Anticholesteremic Agents; Antineoplastic Agents, Hormonal; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Cyclohexanes; Disease Models, Animal; Genetic Therapy; Humans; Immunotherapy; Liver Neoplasms; Meta-Analysis as Topic; Mice; Multicenter Studies as Topic; O-(Chloroacetylcarbamoyl)fumagillol; Octreotide; Pilot Projects; Pravastatin; Primary Prevention; Prognosis; Randomized Controlled Trials as Topic; Risk Factors; Sesquiterpenes; Tamoxifen; Thymus Extracts; Time Factors

2003

Trials

1 trial(s) available for pravastatin and Disease Models, Animal

ArticleYear
Statins exert the pleiotropic effects through small GTP-binding protein dissociation stimulator upregulation with a resultant Rac1 degradation.
    Arteriosclerosis, thrombosis, and vascular biology, 2013, Volume: 33, Issue:7

    Topics: Adaptor Proteins, Signal Transducing; Angiotensin II; Animals; Atorvastatin; Biomarkers; Cardiomegaly; Cells, Cultured; Cholesterol; Cholesterol, LDL; Coronary Vessels; Cross-Over Studies; Cytoskeletal Proteins; Disease Models, Animal; Dose-Response Relationship, Drug; Fibrosis; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Guanine Nucleotide Exchange Factors; Heptanoic Acids; Human Umbilical Vein Endothelial Cells; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Japan; Male; Mice; Mice, Knockout; Neuropeptides; Oxidative Stress; Phosphatidylinositol 3-Kinase; Pravastatin; Proto-Oncogene Proteins c-akt; Pyrroles; Quinolines; rac GTP-Binding Proteins; rac1 GTP-Binding Protein; RNA Interference; Signal Transduction; Transfection

2013

Other Studies

133 other study(ies) available for pravastatin and Disease Models, Animal

ArticleYear
Mouse reduced in osteosclerosis transporter functions as an organic anion transporter 3 and is localized at abluminal membrane of blood-brain barrier.
    The Journal of pharmacology and experimental therapeutics, 2004, Volume: 309, Issue:3

    Topics: Animals; Biological Transport; Blood-Brain Barrier; Capillaries; Disease Models, Animal; Estrone; Male; Membrane Transport Proteins; Mice; Mice, Inbred C57BL; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Osteosclerosis; Penicillin G; RNA, Messenger

2004
Hepatoselectivity of statins: design and synthesis of 4-sulfamoyl pyrroles as HMG-CoA reductase inhibitors.
    Bioorganic & medicinal chemistry letters, 2008, Feb-01, Volume: 18, Issue:3

    Topics: Animals; Atorvastatin; Combinatorial Chemistry Techniques; Disease Models, Animal; Fluorobenzenes; Hepatocytes; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mice; Molecular Structure; Muscle Cells; Pyrimidines; Pyrroles; Rosuvastatin Calcium; Sulfonamides

2008
Statins alone are ineffective in cerebral malaria but potentiate artesunate.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:11

    Topics: Animals; Antimalarials; Artemisinins; Artesunate; Atorvastatin; Disease Models, Animal; Drug Synergism; Fatty Acids, Monounsaturated; Fluvastatin; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Malaria, Cerebral; Malaria, Falciparum; Mice; Neuroprotective Agents; Pravastatin; Pyrroles; Simvastatin

2008
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
    Proceedings of the National Academy of Sciences of the United States of America, 2020, 12-08, Volume: 117, Issue:49

    Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection

2020
Pravastatin attenuates sepsis-induced acute lung injury through decreasing pulmonary microvascular permeability via inhibition of Cav-1/eNOS pathway.
    International immunopharmacology, 2021, Volume: 100

    Topics: Acute Lung Injury; Animals; Apoptosis; Bronchoalveolar Lavage Fluid; Capillary Permeability; Caveolin 1; Disease Models, Animal; Endothelial Cells; Humans; Male; Mice; Nitric Oxide Synthase Type III; Pravastatin; Pulmonary Alveoli; Sepsis

2021
Gut Microbial Metabolite Pravastatin Attenuates Intestinal Ischemia/Reperfusion Injury Through Promoting IL-13 Release From Type II Innate Lymphoid Cells
    Frontiers in immunology, 2021, Volume: 12

    Topics: Animals; Disease Models, Animal; Gastrointestinal Microbiome; Humans; Immunity, Innate; Interleukin-1 Receptor-Like 1 Protein; Interleukin-13; Interleukin-33; Intestinal Diseases; Lymphocytes; Male; Mice; Mice, Knockout; Pravastatin; Reperfusion Injury

2021
Metallothionein 2 activation by pravastatin reinforces epithelial integrity and ameliorates radiation-induced enteropathy.
    EBioMedicine, 2021, Volume: 73

    Topics: Animals; Biopsy; Caco-2 Cells; Computational Biology; Disease Models, Animal; Gene Expression Profiling; Gene Expression Regulation; Gene Ontology; Humans; Intestinal Diseases; Intestinal Mucosa; Male; Metallothionein; Mice; Pravastatin; Radiation Injuries; Radiation, Ionizing; Swine; Swine, Miniature; Tight Junctions

2021
Reply: Investigations of pravastatin for the prevention of preeclampsia.
    American journal of obstetrics and gynecology, 2023, Volume: 229, Issue:2

    Topics: Animals; Disease Models, Animal; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Pravastatin; Pre-Eclampsia; Pregnancy; Vascular Endothelial Growth Factor Receptor-1

2023
Dual-probe molecular MRI for the in vivo characterization of atherosclerosis in a mouse model: Simultaneous assessment of plaque inflammation and extracellular-matrix remodeling.
    Scientific reports, 2019, 09-25, Volume: 9, Issue:1

    Topics: Animals; Contrast Media; Diet, High-Fat; Disease Models, Animal; Elastin; Feasibility Studies; Ferrosoferric Oxide; Gadolinium; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Magnetic Resonance Imaging; Male; Mice; Mice, Knockout, ApoE; Nitric Oxide; Plaque, Atherosclerotic; Pravastatin; Sensitivity and Specificity

2019
Statins Reverse Postpartum Cardiovascular Dysfunction in a Rat Model of Preeclampsia.
    Hypertension (Dallas, Tex. : 1979), 2020, Volume: 75, Issue:1

    Topics: Animals; Cardiac Output; Cardiovascular Diseases; Disease Models, Animal; Female; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Postpartum Period; Pravastatin; Pre-Eclampsia; Pregnancy; Rats; Rats, Sprague-Dawley; Ventricular Remodeling

2020
Interaction of Oatp1b2 expression and nonalcoholic steatohepatitis on pravastatin plasma clearance.
    Biochemical pharmacology, 2020, Volume: 174

    Topics: Animals; Disease Models, Animal; Gene Dosage; Gene Expression; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Liver-Specific Organic Anion Transporter 1; Metabolic Clearance Rate; Mice, Inbred C57BL; Mice, Knockout; Non-alcoholic Fatty Liver Disease; Pravastatin

2020
Phytoconstituents of an ethanolic pod extract of Prosopis cineraria triggers the inhibition of HMG-CoA reductase and the regression of atherosclerotic plaque in hypercholesterolemic rabbits.
    Lipids in health and disease, 2020, Jan-13, Volume: 19, Issue:1

    Topics: Animals; Anticholesteremic Agents; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Disease Models, Animal; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Male; Plant Extracts; Plaque, Atherosclerotic; Pravastatin; Prosopis; Rabbits; Triglycerides

2020
Pravastatin Alleviates Radiation Proctitis by Regulating Thrombomodulin in Irradiated Endothelial Cells.
    International journal of molecular sciences, 2020, Mar-10, Volume: 21, Issue:5

    Topics: Animals; Disease Models, Animal; Endothelial Cells; Female; Gene Expression Regulation; Human Umbilical Vein Endothelial Cells; Humans; Leukocytes; Mice; Pravastatin; Proctitis; THP-1 Cells; Thrombomodulin

2020
Identification of therapeutics that target eEF1A2 and upregulate utrophin A translation in dystrophic muscles.
    Nature communications, 2020, 04-24, Volume: 11, Issue:1

    Topics: 5' Untranslated Regions; Animals; Betaxolol; Cell Line; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Repositioning; Humans; Internal Ribosome Entry Sites; Mice; Mice, Inbred mdx; Mice, Knockout; Muscular Dystrophy, Duchenne; Myoblasts; Peptide Elongation Factor 1; Pravastatin; Protein Biosynthesis; Up-Regulation; Utrophin

2020
Evaluation of musculoskeletal phenotype of the G608G progeria mouse model with lonafarnib, pravastatin, and zoledronic acid as treatment groups.
    Proceedings of the National Academy of Sciences of the United States of America, 2020, 06-02, Volume: 117, Issue:22

    Topics: Aging; Animals; Bone and Bones; Bone Density Conservation Agents; Cartilage; Disease Models, Animal; Femur; Glycosaminoglycans; Joints; Lamin Type A; Mice; Mice, Transgenic; Mutation; Osteoarthritis; Phenotype; Piperidines; Pravastatin; Progeria; Protein Processing, Post-Translational; Pyridines; X-Ray Microtomography; Zoledronic Acid

2020
Pravastatin attenuates atherosclerosis after myocardial infarction by inhibiting inflammatory Ly6C
    The Journal of international medical research, 2020, Volume: 48, Issue:7

    Topics: Animals; Apolipoproteins E; Atherosclerosis; Disease Models, Animal; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardial Infarction; Plaque, Atherosclerotic; Pravastatin

2020
Sustained Focal Vascular Inflammation Accelerates Atherosclerosis in Remote Arteries.
    Arteriosclerosis, thrombosis, and vascular biology, 2020, Volume: 40, Issue:9

    Topics: Animals; Anti-Inflammatory Agents; Aortitis; Atherosclerosis; Brachiocephalic Trunk; Collagen; Disease Models, Animal; Disease Progression; Inflammation Mediators; Interleukin-6; Lipid Metabolism; Male; Mice, Knockout, ApoE; Minocycline; Necrosis; Plaque, Atherosclerotic; Pravastatin; Time Factors

2020
Statin Effects on Vascular Calcification: Microarchitectural Changes in Aortic Calcium Deposits in Aged Hyperlipidemic Mice.
    Arteriosclerosis, thrombosis, and vascular biology, 2021, Volume: 41, Issue:4

    Topics: Age Factors; Animals; Aorta; Aortic Diseases; Atherosclerosis; Calcium; Disease Models, Animal; Female; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Lipids; Mice, Inbred C57BL; Mice, Knockout, ApoE; Plaque, Atherosclerotic; Pravastatin; Rupture, Spontaneous; Time Factors; Vascular Calcification

2021
Pravastatin Decreases Infarct Size Induced by Coronary Artery Ischemia/Reperfusion with Elevated eNOS Expression in Rats.
    International heart journal, 2018, Volume: 59, Issue:1

    Topics: Animals; Coronary Vessels; Disease Models, Animal; Dose-Response Relationship, Drug; Electrophoresis, Polyacrylamide Gel; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Myocardial Infarction; Myocardium; Nitric Oxide Synthase Type III; Pravastatin; Rats; Rats, Sprague-Dawley; Reperfusion Injury; RNA

2018
Different Effects of Pravastatin on Preeclampsia-like Symptoms in Different Mouse Models.
    Chinese medical journal, 2018, Feb-20, Volume: 131, Issue:4

    Topics: Animals; Arterial Pressure; Disease Models, Animal; Female; Male; Mice; Mice, Inbred C57BL; NG-Nitroarginine Methyl Ester; Pravastatin; Pre-Eclampsia; Pregnancy

2018
Pravastatin improves risk factors but not ischaemic tolerance in obese rats.
    European journal of pharmacology, 2018, May-05, Volume: 826

    Topics: Animals; Blood Glucose; Body Weight; Diet, Carbohydrate Loading; Diet, High-Fat; Disease Models, Animal; Heart; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertriglyceridemia; Insulin Resistance; Lipid Peroxidation; Male; Mitochondria; Mitochondrial Dynamics; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Obesity; Pravastatin; Rats; Rats, Wistar; Risk Factors

2018
Effect of the anti-IL-17 antibody on allergic inflammation in an obesity-related asthma model.
    The Korean journal of internal medicine, 2018, Volume: 33, Issue:6

    Topics: Adiponectin; Adipose Tissue; Animals; Anti-Asthmatic Agents; Antibodies; Asthma; Bronchoconstriction; Diet, High-Fat; Disease Models, Animal; Female; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Interleukin-17; Leptin; Lung; Mice, Inbred C57BL; Obesity; Pravastatin; Th17 Cells; Th2 Cells

2018
Pravastatin therapy during preeclampsia prevents long-term adverse health effects in mice.
    JCI insight, 2018, 04-19, Volume: 3, Issue:8

    Topics: Animals; Cardiovascular Diseases; Disease Models, Animal; Endothelin-1; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Male; Mice; Mice, Inbred C57BL; Placenta; Pravastatin; Pre-Eclampsia; Pregnancy; Risk Factors; Vascular Remodeling

2018
Pravastatin polarizes the phenotype of macrophages toward M2 and elevates serum cholesterol levels in apolipoprotein E knockout mice.
    The Journal of international medical research, 2018, Volume: 46, Issue:8

    Topics: Animals; Anticholesteremic Agents; Aortic Diseases; Apolipoproteins E; Atherosclerosis; Cholesterol; Disease Models, Animal; Macrophages; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Phenotype; Plaque, Atherosclerotic; Pravastatin

2018
Pravastatin improves atherosclerosis in mice with hyperlipidemia by inhibiting TREM-1/DAP12.
    European review for medical and pharmacological sciences, 2018, Volume: 22, Issue:15

    Topics: Adaptor Proteins, Signal Transducing; Animals; Anticholesteremic Agents; Apolipoproteins E; Atherosclerosis; Disease Models, Animal; Hyperlipidemias; Interleukin-1; Mice; Mice, Inbred C57BL; Mice, Knockout; Plaque, Atherosclerotic; Pravastatin; Triggering Receptor Expressed on Myeloid Cells-1; Tumor Necrosis Factor-alpha

2018
Placental nitric oxide formation and endothelium-dependent vasodilation underlie pravastatin effects against angiogenic imbalance, hypertension in pregnancy and intrauterine growth restriction.
    Basic & clinical pharmacology & toxicology, 2019, Volume: 124, Issue:4

    Topics: Animals; Blood Pressure; Disease Models, Animal; Endothelium, Vascular; Female; Fetal Growth Retardation; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension, Pregnancy-Induced; Neovascularization, Physiologic; Nitric Oxide; Oxidative Stress; Placenta; Pravastatin; Pre-Eclampsia; Pregnancy; Rats; Rats, Wistar; Vasodilation

2019
Combination therapy with cilostazol and pravastatin improves antiatherogenic effects in low-density lipoprotein receptor knockout mice.
    Cardiovascular therapeutics, 2018, Volume: 36, Issue:6

    Topics: Animals; Aorta; Aortic Diseases; Atherosclerosis; Cell Adhesion Molecules; Cholesterol, Dietary; Cilostazol; Cytokines; Diet, High-Fat; Disease Models, Animal; Drug Therapy, Combination; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation Mediators; Lipids; Male; Mice, Inbred C57BL; Mice, Knockout; Plaque, Atherosclerotic; Platelet Aggregation Inhibitors; Pravastatin; Receptors, LDL

2018
A Comparison of the Anti-Inflammatory Effects of Four Combined Statin and Antiplatelet Therapies on Tumor Necrosis Factor-Mediated Acute Inflammation in vivo.
    Pharmacology, 2019, Volume: 104, Issue:1-2

    Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Cilostazol; Clopidogrel; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Therapy, Combination; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Lipopolysaccharides; Male; Mice; Platelet Aggregation Inhibitors; Pravastatin; Rosuvastatin Calcium; Treatment Outcome; Tumor Necrosis Factor-alpha

2019
Pravastatin attenuates hypertension, oxidative stress, and angiogenic imbalance in rat model of placental ischemia-induced hypertension.
    Hypertension (Dallas, Tex. : 1979), 2013, Volume: 61, Issue:5

    Topics: Animals; Blood Pressure; Cells, Cultured; Disease Models, Animal; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Ischemia; Neovascularization, Physiologic; Oxidative Stress; Placenta; Pravastatin; Pre-Eclampsia; Pregnancy; Rats; Rats, Sprague-Dawley; Thiobarbituric Acid Reactive Substances; Trophoblasts; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1

2013
Effects of pravastatin on angiogenic and placental hypoxic imbalance in a mouse model of preeclampsia.
    Reproductive sciences (Thousand Oaks, Calif.), 2014, Volume: 21, Issue:1

    Topics: Adenoviridae; Animals; Cell Hypoxia; Disease Models, Animal; Endoglin; Female; Gene Expression Regulation; Gene Transfer Techniques; Genetic Vectors; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intracellular Signaling Peptides and Proteins; Mice; Neovascularization, Physiologic; Placenta; Placenta Growth Factor; Pravastatin; Pre-Eclampsia; Pregnancy; Pregnancy Proteins; RNA, Messenger; Signal Transduction; Time Factors; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1

2014
Increased inducibility of ventricular tachycardia and decreased heart rate variability in a mouse model for type 1 diabetes: effect of pravastatin.
    American journal of physiology. Heart and circulatory physiology, 2013, Volume: 305, Issue:12

    Topics: Animals; Diabetes Mellitus, Type 1; Disease Models, Animal; Heart Rate; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mice; Pravastatin; Tachycardia, Ventricular

2013
The effect of maternal pravastatin therapy on adverse sensorimotor outcomes of the offspring in a murine model of preeclampsia.
    International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience, 2014, Volume: 33

    Topics: Analysis of Variance; Animals; Anticholesteremic Agents; Disease Models, Animal; Female; Fetal Development; Gait Disorders, Neurologic; Humans; Male; Mice; Postural Balance; Pravastatin; Pre-Eclampsia; Pregnancy; Prenatal Exposure Delayed Effects; Psychomotor Disorders; Reflex; Sex Factors; Transduction, Genetic; Vascular Endothelial Growth Factor Receptor-1

2014
The effect of prenatal pravastatin treatment on altered fetal programming of postnatal growth and metabolic function in a preeclampsia-like murine model.
    American journal of obstetrics and gynecology, 2014, Volume: 210, Issue:6

    Topics: Analysis of Variance; Animals; Area Under Curve; Blood Glucose; Body Weight; Cell Cycle Proteins; Disease Models, Animal; Female; Fetal Development; Insulin; Male; Mice; Pravastatin; Pre-Eclampsia; Pregnancy; Receptors, G-Protein-Coupled; Vascular Endothelial Growth Factor Receptor-1

2014
Pravastatin prevents steroid-induced osteonecrosis in rats by suppressing PPARγ expression and activating Wnt signaling pathway.
    Experimental biology and medicine (Maywood, N.J.), 2014, Volume: 239, Issue:3

    Topics: Adipogenesis; Adipose Tissue; Adrenal Cortex Hormones; Animals; beta Catenin; Core Binding Factor Alpha 1 Subunit; Disease Models, Animal; Femur Head; Femur Head Necrosis; Fibrinolysis; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Lipids; Low Density Lipoprotein Receptor-Related Protein-5; Male; Methylprednisolone; Neovascularization, Physiologic; Osteogenesis; Osteonecrosis; PPAR gamma; Pravastatin; Rats; Rats, Wistar; Wnt Signaling Pathway; Wnt3A Protein

2014
Extravascular optical coherence tomography: evaluation of carotid atherosclerosis and pravastatin therapy.
    Stroke, 2014, Volume: 45, Issue:4

    Topics: Animals; Apolipoproteins E; Carotid Artery Diseases; Carotid Stenosis; Disease Models, Animal; Drug Monitoring; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Imaging, Three-Dimensional; Mice; Mice, Inbred C57BL; Mice, Knockout; Pravastatin; Random Allocation; Tomography, Optical Coherence

2014
The anti-inflammatory and antioxidant effects of pravastatin and nebivolol in rat aorta.
    Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology, 2014, Volume: 14, Issue:3

    Topics: Adrenergic beta-1 Receptor Antagonists; Animals; Aorta; Ceruloplasmin; Cholesterol; Coronary Artery Disease; Disease Models, Animal; Female; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Nebivolol; NG-Nitroarginine Methyl Ester; Pravastatin; Rats; Rats, Wistar; Triglycerides; Uric Acid

2014
Maternal pravastatin prevents altered fetal brain development in a preeclamptic CD-1 mouse model.
    PloS one, 2014, Volume: 9, Issue:6

    Topics: Animals; Brain; Brain Mapping; Disease Models, Animal; Female; Fetal Development; Fetus; Image Processing, Computer-Assisted; Immunoenzyme Techniques; Magnetic Resonance Imaging; Male; Mice; Pravastatin; Pre-Eclampsia; Pregnancy; Vascular Endothelial Growth Factor Receptor-1

2014
Melatonin potentiates the anti-tumour effect of pravastatin in rat mammary gland carcinoma model.
    International journal of experimental pathology, 2014, Volume: 95, Issue:6

    Topics: Alkylating Agents; Animals; Antineoplastic Agents; Antioxidants; Apoptosis; Carcinoma in Situ; Carcinoma, Ductal, Breast; Carcinoma, Papillary; Disease Models, Animal; Drug Synergism; Female; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mammary Neoplasms, Experimental; Melatonin; Methylnitrosourea; Pravastatin; Rats, Sprague-Dawley

2014
Ex vivo exposure of bone marrow from chronic kidney disease donor rats to pravastatin limits renal damage in recipient rats with chronic kidney disease.
    Stem cell research & therapy, 2015, Apr-15, Volume: 6

    Topics: Animals; Apoptosis; Blood Pressure; Body Weight; Bone Marrow Cells; Bone Marrow Transplantation; Cell Movement; Chemokine CXCL5; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Glomerular Filtration Rate; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney; Male; Pravastatin; Rats; Rats, Inbred Lew; Renal Insufficiency, Chronic; Tissue Donors; Transplantation, Homologous

2015
Co-administration of paroxetine increased the systemic exposure of pravastatin in diabetic rats due to the decrease in liver distribution.
    Xenobiotica; the fate of foreign compounds in biological systems, 2015, Volume: 45, Issue:9

    Topics: Administration, Intravenous; Administration, Oral; Animals; Body Fluids; Carbamates; Cell Separation; Diabetes Mellitus, Experimental; Diet, High-Fat; Disease Models, Animal; Feces; Hepatocytes; Intestinal Absorption; Liver; Male; Paroxetine; Piperidines; Pravastatin; Rats, Sprague-Dawley; Tissue Distribution

2015
SmgGDS as a Crucial Mediator of the Inhibitory Effects of Statins on Cardiac Hypertrophy and Fibrosis: Novel Mechanism of the Pleiotropic Effects of Statins.
    Hypertension (Dallas, Tex. : 1979), 2016, Volume: 67, Issue:5

    Topics: Adaptor Proteins, Signal Transducing; Animals; Blotting, Western; Cardiomegaly; Cell Proliferation; Cells, Cultured; Chemokines; Cytoskeletal Proteins; Disease Models, Animal; Fibrosis; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mice; Myocytes, Cardiac; Pravastatin; Random Allocation; Rats; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; Role; Species Specificity

2016
Pravastatin Effects on Placental Prosurvival Molecular Pathways in a Mouse Model of Preeclampsia.
    Reproductive sciences (Thousand Oaks, Calif.), 2016, Volume: 23, Issue:11

    Topics: Animals; Apoptosis; Disease Models, Animal; Female; HSP27 Heat-Shock Proteins; MAP Kinase Signaling System; Mice; Phosphorylation; Placenta; Pravastatin; Pre-Eclampsia; Pregnancy; STAT3 Transcription Factor; Vascular Endothelial Growth Factor Receptor-1

2016
Pravastatin activates activator protein 2 alpha to augment the angiotensin II-induced abdominal aortic aneurysms.
    Oncotarget, 2017, Feb-28, Volume: 8, Issue:9

    Topics: AMP-Activated Protein Kinases; Angiotensin II; Animals; Anticholesteremic Agents; Aortic Aneurysm, Abdominal; Apolipoproteins E; Blotting, Western; Cells, Cultured; Disease Models, Animal; Gene Expression Regulation; Humans; Male; Mice; Mice, Knockout; Myocytes, Smooth Muscle; Phosphorylation; Pravastatin; Signal Transduction; Transcription Factor AP-2

2017
Rejuvenating premature aging.
    Nature medicine, 2008, Volume: 14, Issue:7

    Topics: Animals; Bone Density Conservation Agents; Cell Nucleus; Diphosphonates; Disease Models, Animal; Drug Therapy, Combination; Farnesyltranstransferase; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Imidazoles; Lamin Type A; Longevity; Mice; Mice, Knockout; Nuclear Proteins; Pravastatin; Prenylation; Progeria; Protein Precursors; Tumor Suppressor Protein p53; Zoledronic Acid

2008
Multiple effects of HMG-CoA reductase inhibitors (statins) besides their lipid-lowering function.
    Kidney international, 2008, Volume: 74, Issue:5

    Topics: Animals; Cholesterol; Disease Models, Animal; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Inflammation; Interleukin-6; Kidney; Mice; Pravastatin; Reperfusion Injury

2008
Statin ameliorates hypoxia-induced pulmonary hypertension associated with down-regulated stromal cell-derived factor-1.
    Cardiovascular research, 2009, Jan-01, Volume: 81, Issue:1

    Topics: Actins; Animals; Bone Marrow Cells; CD18 Antigens; Cell Differentiation; Cells, Cultured; Chemokine CXCL12; Disease Models, Animal; Down-Regulation; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension, Pulmonary; Hypoxia; Intercellular Adhesion Molecule-1; Mice; Mice, Inbred BALB C; Muscle, Smooth, Vascular; Pravastatin; Proto-Oncogene Proteins c-kit; Receptors, CXCR4; Stem Cells; Vascular Endothelial Growth Factor Receptor-2

2009
Pravastatin improves function in hibernating myocardium by mobilizing CD133+ and cKit+ bone marrow progenitor cells and promoting myocytes to reenter the growth phase of the cardiac cell cycle.
    Circulation research, 2009, Jan-30, Volume: 104, Issue:2

    Topics: AC133 Antigen; Animals; Antigens, CD; Bone Marrow Cells; Cell Movement; Cell Proliferation; Coronary Circulation; Coronary Stenosis; Disease Models, Animal; Dose-Response Relationship, Drug; GATA4 Transcription Factor; Glycoproteins; Hemodynamics; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mitosis; Muscle Development; Myocardial Contraction; Myocytes, Cardiac; Peptides; Pravastatin; Proto-Oncogene Proteins c-kit; Regeneration; Stem Cells; Swine

2009
[Effects of pravastatin on myocardial connexin 43, IFN-gamma and IL-10 expressions in a murine model of viral myocarditis induced by Coxsackievirus B3].
    Zhonghua xin xue guan bing za zhi, 2008, Volume: 36, Issue:1

    Topics: Animals; Connexin 43; Coxsackievirus Infections; Disease Models, Animal; Interferon-gamma; Interleukin-10; Male; Mice; Mice, Inbred BALB C; Myocarditis; Myocardium; Pravastatin

2008
3-Hydroxy-3-methylglutaryl (HMG)-COA reductase inhibitors and phosphodiesterase type V inhibitors attenuate right ventricular pressure and remodeling in a rat model of pulmonary hypertension.
    Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques, 2009, Feb-04, Volume: 11, Issue:2

    Topics: Animals; Atorvastatin; Disease Models, Animal; Hemodynamics; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension, Pulmonary; Male; Monocrotaline; Phosphodiesterase Inhibitors; Pravastatin; Pulmonary Artery; Pyrroles; Rats; Rats, Wistar; Simvastatin

2009
Pravastatin limits radiation-induced vascular dysfunction in the skin.
    The Journal of investigative dermatology, 2009, Volume: 129, Issue:5

    Topics: Animals; Blood Vessels; Cell Communication; Chemokine CCL2; Chemokine CXCL1; Disease Models, Animal; E-Selectin; Endothelium, Vascular; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intercellular Adhesion Molecule-1; Leukocytes; Male; Mice; Mice, Inbred BALB C; Mice, Knockout; Nitric Oxide; Nitric Oxide Synthase Type III; Pravastatin; Radiodermatitis; Radiotherapy; Skin

2009
Pravastatin prevents miscarriages in mice: role of tissue factor in placental and fetal injury.
    Blood, 2009, Apr-23, Volume: 113, Issue:17

    Topics: Abortion, Spontaneous; Animals; Animals, Newborn; Anticoagulants; Antithrombin III; Cells, Cultured; Disease Models, Animal; Female; Humans; Infant, Newborn; Male; Mice; Monocytes; Nitrogen Oxides; Oxidative Stress; Placenta; Pravastatin; Pregnancy; Protein Binding; Thrombin; Thromboplastin; Trophoblasts; Vascular Endothelial Growth Factor Receptor-1

2009
Oral apolipoprotein A-I mimetic peptide improves cognitive function and reduces amyloid burden in a mouse model of Alzheimer's disease.
    Neurobiology of disease, 2009, Volume: 34, Issue:3

    Topics: Administration, Oral; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Anticholesteremic Agents; Apolipoprotein A-I; Astrocytes; Chemokine CCL2; Cholesterol; Cognition; Disease Models, Animal; Drug Therapy, Combination; Hippocampus; Interleukin-1beta; Male; Maze Learning; Mice; Mice, Transgenic; Microglia; Plaque, Amyloid; Pravastatin; Protease Nexins; Receptors, Cell Surface; Tumor Necrosis Factor-alpha

2009
Characteristic changes in coronary artery at the early hyperglycaemic stage in a rat type 2 diabetes model and the effects of pravastatin.
    British journal of pharmacology, 2009, Volume: 158, Issue:2

    Topics: Animals; Coronary Vessels; Diabetes Mellitus, Type 2; Disease Models, Animal; Gene Expression Regulation; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperglycemia; Male; Nitric Oxide Synthase Type III; Pravastatin; Rats; Rats, Inbred OLETF; Rats, Long-Evans; Superoxides

2009
Simvastatin inhibits the activation of p21ras and prevents the loss of dopaminergic neurons in a mouse model of Parkinson's disease.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2009, Oct-28, Volume: 29, Issue:43

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Aged; Animals; Cell Survival; Disease Models, Animal; Dopamine; Humans; Male; Mice; Mice, Inbred C57BL; Motor Activity; Neuroglia; Neurons; Neuroprotective Agents; Neurotransmitter Agents; NF-kappa B; Parkinson Disease; Parkinsonian Disorders; Pravastatin; Proto-Oncogene Proteins p21(ras); Simvastatin; Substantia Nigra

2009
Synergistic antifibrotic efficacy of statin and protein kinase C inhibitor in hepatic fibrosis.
    American journal of physiology. Gastrointestinal and liver physiology, 2010, Volume: 298, Issue:1

    Topics: Animals; Apoptosis; Body Weight; Carbon Tetrachloride; Cell Line, Transformed; Disease Models, Animal; Drug Synergism; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Liver Cirrhosis; Male; Mice; Mice, Inbred BALB C; Mitochondria; Organ Size; Pravastatin; Protein Kinase C; Protein Kinase Inhibitors; Thioacetamide

2010
Low-dosage statins reduce choroidal damage in hypercholesterolemic rabbits.
    Acta ophthalmologica, 2011, Volume: 89, Issue:7

    Topics: Animals; Anticholesteremic Agents; Cholesterol; Cholesterol, Dietary; Choroid; Choroid Diseases; Disease Models, Animal; Endothelium, Vascular; Fatty Acids, Monounsaturated; Fluvastatin; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Indoles; Male; Muscle, Smooth, Vascular; Pravastatin; Rabbits; Triglycerides

2011
Effect of olmesartan and pravastatin on experimental cerebral aneurysms in rats.
    Brain research, 2010, Mar-31, Volume: 1322

    Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Cerebral Arteries; Circle of Willis; Corrosion Casting; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Endothelial Cells; Hydralazine; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Imidazoles; Intracranial Aneurysm; Microscopy, Electron, Scanning; Pravastatin; Rats; Tetrazoles; Treatment Outcome; Vasodilator Agents

2010
Mitochondrial K(ATP) channels-derived reactive oxygen species activate pro-survival pathway in pravastatin-induced cardioprotection.
    Apoptosis : an international journal on programmed cell death, 2010, Volume: 15, Issue:6

    Topics: Animals; Cell Survival; Cells, Cultured; Disease Models, Animal; Heart; Humans; In Vitro Techniques; Male; Myocardial Infarction; Myocytes, Cardiac; Potassium Channels; Pravastatin; Protective Agents; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species

2010
Effect of pravastatin on ventricular arrhythmias in infarcted rats: role of connexin43.
    Journal of applied physiology (Bethesda, Md. : 1985), 2010, Volume: 109, Issue:2

    Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Blotting, Western; Bosentan; Cardiac Pacing, Artificial; Connexin 43; Disease Models, Animal; Drug Therapy, Combination; Endothelin Receptor Antagonists; Endothelin-1; Fluorescent Antibody Technique; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Male; Maleimides; Mevalonic Acid; Myocardial Infarction; Myocardium; Pravastatin; Protein Kinase C; Protein Kinase Inhibitors; Rats; Rats, Wistar; Receptors, Endothelin; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sulfonamides; Time Factors; Ultrasonography

2010
Treatment with apolipoprotein A-1 mimetic peptide reduces lupus-like manifestations in a murine lupus model of accelerated atherosclerosis.
    Arthritis research & therapy, 2010, Volume: 12, Issue:3

    Topics: Animals; Apolipoprotein A-I; Apolipoproteins E; Bone Density; Chemokines; Cytokines; Disease Models, Animal; fas Receptor; Female; Immunoglobulin G; Lipids; Lupus Erythematosus, Systemic; Mice; Mice, Inbred C57BL; Mice, Knockout; Peptides; Plaque, Atherosclerotic; Pravastatin

2010
Reduction of endoplasmic reticulum stress--a novel mechanism of action of statins in the protection against atherosclerosis.
    Atherosclerosis, 2010, Volume: 212, Issue:1

    Topics: Animals; Antigens, Differentiation; Atherosclerosis; Cell Line; Disease Models, Animal; DNA-Binding Proteins; eIF-2 Kinase; Endoplasmic Reticulum; Endoplasmic Reticulum Chaperone BiP; Eukaryotic Initiation Factor-2; Fatty Acids; Heat-Shock Proteins; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Macrophages; Mice; Mice, Knockout; Phosphorylation; Pravastatin; Receptors, LDL; Regulatory Factor X Transcription Factors; Simvastatin; Stress, Physiological; Transcription Factors

2010
Preventive effects of pravastatin on thrombin-triggered vascular responses via Akt/eNOS and RhoA/Rac1 pathways in vivo.
    Cardiovascular research, 2010, Dec-01, Volume: 88, Issue:3

    Topics: Animals; Anticholesteremic Agents; Aorta; Coronary Vessels; Disease Models, Animal; Guanosine Triphosphate; Injections, Intravenous; Male; NADPH Oxidases; Nitric Oxide Synthase Type III; Pravastatin; Proto-Oncogene Proteins c-akt; rac1 GTP-Binding Protein; Rats; Rats, Inbred SHR; Rats, Wistar; Reactive Oxygen Species; rhoA GTP-Binding Protein; Signal Transduction; Thrombin; Vasodilation

2010
Effect of pravastatin on bleomycin-induced acute lung injury and pulmonary fibrosis.
    Clinical and experimental pharmacology & physiology, 2010, Volume: 37, Issue:11

    Topics: Acute Lung Injury; Animals; Anti-Inflammatory Agents; Bleomycin; Blotting, Western; Bronchoalveolar Lavage Fluid; Connective Tissue Growth Factor; Cyclin D1; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Female; Gene Expression; Hydroxyproline; Mice; Mice, Inbred C57BL; Pravastatin; Pulmonary Fibrosis; Respiratory Distress Syndrome; Reverse Transcriptase Polymerase Chain Reaction; rho GTP-Binding Proteins; rhoA GTP-Binding Protein; Transforming Growth Factor beta1

2010
Pravastatin administration does not induce detrimental effects on hemodynamics and collaterals of portal hypertensive rats.
    Journal of gastroenterology and hepatology, 2010, Volume: 25, Issue:8

    Topics: Animals; Collateral Circulation; Cyclooxygenase Inhibitors; Disease Models, Animal; Dose-Response Relationship, Drug; Endothelin-1; Enzyme Inhibitors; Hemodynamics; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension, Portal; Indomethacin; Male; Nitric Oxide Synthase; Nitroarginine; Portal System; Pravastatin; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Time Factors; Vascular Resistance; Vasoconstriction; Vasoconstrictor Agents

2010
A new mouse model to explore therapies for preeclampsia.
    PloS one, 2010, Oct-27, Volume: 5, Issue:10

    Topics: Animals; Blood Pressure; Disease Models, Animal; Female; Leptin; Mice; Mice, Inbred CBA; Mice, Inbred DBA; Pravastatin; Pre-Eclampsia; Pregnancy; Pregnancy Outcome; Vascular Endothelial Growth Factor A

2010
Influence of long-term treatment with pravastatin on the survival, evolution of cutaneous lesion and weight of animals infected by Leishmania amazonensis.
    Experimental parasitology, 2011, Volume: 127, Issue:3

    Topics: Analysis of Variance; Animals; Antiprotozoal Agents; Body Weight; Cricetinae; Disease Models, Animal; Disease Susceptibility; Dose-Response Relationship, Drug; Female; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Leishmania mexicana; Leishmaniasis, Cutaneous; Male; Mesocricetus; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Pravastatin; Statistics, Nonparametric; Survival Rate

2011
Pravastatin induces placental growth factor (PGF) and ameliorates preeclampsia in a mouse model.
    Proceedings of the National Academy of Sciences of the United States of America, 2011, Jan-25, Volume: 108, Issue:4

    Topics: Animals; Animals, Newborn; Cell Line; Disease Models, Animal; Female; HEK293 Cells; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Injections, Intraperitoneal; Lentivirus; Male; Mice; Mice, Transgenic; Placenta; Placenta Growth Factor; Pravastatin; Pre-Eclampsia; Pregnancy; Pregnancy Proteins; Transduction, Genetic; Vascular Endothelial Growth Factor Receptor-1

2011
Preeclampsia: animal models for a human cure.
    Proceedings of the National Academy of Sciences of the United States of America, 2011, Jan-25, Volume: 108, Issue:4

    Topics: Animals; Animals, Newborn; Disease Models, Animal; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lentivirus; Male; Mice; Mice, Transgenic; Placenta; Placenta Growth Factor; Pravastatin; Pre-Eclampsia; Pregnancy; Pregnancy Proteins; Transduction, Genetic; Vascular Endothelial Growth Factor Receptor-1

2011
Pravastatin modulates liver bile acid and cholesterol homeostasis in rats with chronic cholestasis.
    Journal of gastroenterology and hepatology, 2011, Volume: 26, Issue:10

    Topics: Animals; Bile Acids and Salts; Cholestasis; Cholesterol; Chronic Disease; Disease Models, Animal; Gene Expression Regulation, Enzymologic; Homeostasis; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Liver; Male; Membrane Transport Proteins; Permeability; Pravastatin; Rats; Rats, Wistar; RNA, Messenger; Time Factors; Transcription Factors

2011
Statins promote the growth of experimentally induced cerebral aneurysms in estrogen-deficient rats.
    Stroke, 2011, Volume: 42, Issue:8

    Topics: Animals; Apoptosis; Brain; Cells, Cultured; Disease Models, Animal; Endothelial Cells; Estrogens; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Intracranial Aneurysm; Nitric Oxide Synthase Type III; Pravastatin; Rats; Rats, Sprague-Dawley; Simvastatin

2011
The neuroprotective effect of two statins: simvastatin and pravastatin on a streptozotocin-induced model of Alzheimer's disease in rats.
    Journal of neural transmission (Vienna, Austria : 1996), 2011, Volume: 118, Issue:11

    Topics: Alzheimer Disease; Animals; Disease Models, Animal; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Neuroprotective Agents; Pravastatin; Rats; Rats, Wistar; Simvastatin; Streptozocin

2011
Pravastatin for thioacetamide-induced hepatic failure and encephalopathy.
    European journal of clinical investigation, 2012, Volume: 42, Issue:2

    Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Disease Models, Animal; Hepatic Encephalopathy; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Liver; Liver Failure, Acute; Male; Nitric Oxide; Nitric Oxide Synthase; Pravastatin; Rats; Rats, Sprague-Dawley; Thioacetamide

2012
Role of complement component C1q in the onset of preeclampsia in mice.
    Hypertension (Dallas, Tex. : 1979), 2011, Volume: 58, Issue:4

    Topics: Animals; Blood Pressure; Cell Movement; Collagenases; Complement C1q; Disease Models, Animal; Female; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mice; Mice, Knockout; Placenta; Pravastatin; Pre-Eclampsia; Pregnancy; Regional Blood Flow; Trophoblasts; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1

2011
Pravastatin reduces Marfan aortic dilation.
    Circulation, 2011, Sep-13, Volume: 124, Issue:11 Suppl

    Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Aorta; Aortic Diseases; Dilatation, Pathologic; Disease Models, Animal; Elastin; Endoplasmic Reticulum; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Losartan; Male; Marfan Syndrome; Mice; Mice, Mutant Strains; Muscle, Smooth, Vascular; Pravastatin; Treatment Outcome; Tunica Media

2011
Modification of hepatic iron metabolism induced by pravastatin during obstructive cholestasis in rats.
    Life sciences, 2011, Nov-07, Volume: 89, Issue:19-20

    Topics: Animals; Antimicrobial Cationic Peptides; Cation Transport Proteins; Cholestasis; Disease Models, Animal; Gene Expression Regulation; Heme Oxygenase-1; Hepcidins; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Iron; Liver; Male; Pravastatin; Rats; Rats, Wistar

2011
Pravastatin inhibits farnesol production in Candida albicans and improves survival in a mouse model of systemic candidiasis.
    Medical mycology, 2012, Volume: 50, Issue:4

    Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis; Colony Count, Microbial; Disease Models, Animal; Farnesol; Female; Mice; Mice, Inbred C3H; Pravastatin; Survival Analysis; Virulence Factors

2012
Effects of pravastatin on mediators of vascular function in a mouse model of soluble Fms-like tyrosine kinase-1-induced preeclampsia.
    American journal of obstetrics and gynecology, 2011, Volume: 205, Issue:4

    Topics: Animals; Disease Models, Animal; Female; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mice; Pravastatin; Pre-Eclampsia; Pregnancy; Vascular Endothelial Growth Factor Receptor-1

2011
HMG-CoA reductase inhibitors (statins) reduce hypertrophic scar formation in a rabbit ear wounding model.
    Plastic and reconstructive surgery, 2012, Volume: 129, Issue:2

    Topics: Animals; Cicatrix, Hypertrophic; Disease Models, Animal; Ear; Female; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Pravastatin; Rabbits; Simvastatin; Wound Healing

2012
Pravastatin reduces steroid-induced osteonecrosis of the femoral head in SHRSP rats.
    Acta orthopaedica, 2012, Volume: 83, Issue:1

    Topics: Adipocytes; Animals; Anti-Inflammatory Agents; Bone Marrow; Disease Models, Animal; Drinking Water; Femur Head Necrosis; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunohistochemistry; Lipid Metabolism; Male; Methylprednisolone; Methylprednisolone Acetate; Oxidative Stress; Pravastatin; Rats; Rats, Inbred SHR

2012
Short-term statin administration in hypercholesterolaemic rabbits resistant to postconditioning: effects on infarct size, endothelial nitric oxide synthase, and nitro-oxidative stress.
    Cardiovascular research, 2012, Jun-01, Volume: 94, Issue:3

    Topics: Animals; Anticholesteremic Agents; Disease Models, Animal; Hypercholesterolemia; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Nitric Oxide; Nitric Oxide Synthase Type III; Oxidative Stress; Pravastatin; Proto-Oncogene Proteins c-akt; Rabbits; Simvastatin

2012
Pravastatin normalizes ET-1-induced contraction in the aorta of type 2 diabetic OLETF rats by suppressing the KSR1/ERK complex.
    American journal of physiology. Heart and circulatory physiology, 2012, Oct-01, Volume: 303, Issue:7

    Topics: Animals; Aorta, Thoracic; Aortic Diseases; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Disease Models, Animal; Dose-Response Relationship, Drug; Endothelin-1; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Phosphorylation; Pravastatin; Protein Kinases; Protein Phosphatase 2; Rats; Rats, Inbred OLETF; Signal Transduction; src-Family Kinases; Time Factors; Vasoconstriction; Vasoconstrictor Agents

2012
Can statins reduce the inflammatory response associated with preterm birth in an animal model?
    American journal of obstetrics and gynecology, 2012, Volume: 207, Issue:3

    Topics: Animals; Disease Models, Animal; Female; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Mice; Pravastatin; Pregnancy; Premature Birth; Simvastatin

2012
Pravastatin inhibits plaque rupture and subsequent thrombus formation in atherosclerotic rabbits with hyperlipidemia.
    Chemical & pharmaceutical bulletin, 2013, Volume: 61, Issue:2

    Topics: 6-Ketoprostaglandin F1 alpha; Animals; Anticholesteremic Agents; Aorta; Aorta, Abdominal; Atherosclerosis; Cholesterol; Cholesterol, LDL; Diet, High-Fat; Disease Models, Animal; Histamine; Hyperlipidemias; Male; Plaque, Atherosclerotic; Pravastatin; Rabbits; Thrombosis; Thromboxane B2; Triglycerides; Viper Venoms

2013
Protective effect of pravastatin on lipopolysaccharide-induced acute lung injury during neutropenia recovery in mice.
    Experimental lung research, 2013, Volume: 39, Issue:2

    Topics: Acute Lung Injury; Animals; Bronchoalveolar Lavage Fluid; Cyclophosphamide; Disease Models, Animal; Female; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunosuppressive Agents; Interleukin-1beta; Interleukin-6; Lipopolysaccharides; Mice; Mice, Inbred ICR; Neutropenia; NF-kappa B; Pravastatin; Pulmonary Edema; Respiratory Distress Syndrome; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha

2013
The 3-hydroxy-3-methylglutaryl-CoA reductase inhibitor pravastatin reduces disease activity and inflammation in dextran-sulfate induced colitis.
    The Journal of pharmacology and experimental therapeutics, 2003, Volume: 305, Issue:1

    Topics: Animals; Cell Adhesion Molecules; Cell Membrane Permeability; Cholesterol; Colitis; Dextran Sulfate; Disease Models, Animal; Enzyme Inhibitors; Epithelial Cells; Gene Expression; Hydroxymethylglutaryl CoA Reductases; Immunoglobulins; Immunohistochemistry; Inflammation; Mice; Mice, Inbred C57BL; Mice, Knockout; Mucoproteins; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Pravastatin; RNA, Messenger

2003
Effects of atorvastatin and pravastatin on glucose tolerance in diabetic rats mildly induced by streptozotocin.
    Biological & pharmaceutical bulletin, 2003, Volume: 26, Issue:12

    Topics: Administration, Oral; Animals; Atorvastatin; Blood Glucose; Diabetes Mellitus, Experimental; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Glucose; Glucose Tolerance Test; Heptanoic Acids; Injections, Intravenous; Insulin; Insulin Secretion; Male; Pravastatin; Pyrroles; Rats; Rats, Sprague-Dawley; Streptozocin; Time Factors

2003
Pravastatin decreases cold ischemia--but not alloantigen-dependent transplant arteriosclerosis.
    Transplantation proceedings, 2003, Volume: 35, Issue:8

    Topics: Animals; Aorta, Abdominal; Arteriosclerosis; Cold Temperature; Disease Models, Animal; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ischemia; Isoantigens; Male; Pravastatin; Rats; Rats, Inbred BN; Rats, Inbred Lew; Transplantation, Homologous; Transplantation, Isogeneic; Tunica Intima

2003
Comparison of urinary excretion of pravastatin and temocapril in bile duct-ligated rats and Eisai hyperbilirubinemic rats (EHBR).
    Journal of hepato-biliary-pancreatic surgery, 2004, Volume: 11, Issue:2

    Topics: Animals; Bile Ducts; Cholestasis; Disease Models, Animal; Hyperbilirubinemia; Male; Pravastatin; Rats; Rats, Sprague-Dawley; Thiazepines

2004
Effects of pravastatin on progression of glucose intolerance and cardiovascular remodeling in a type II diabetes model.
    Journal of the American College of Cardiology, 2004, Aug-18, Volume: 44, Issue:4

    Topics: Animals; Blood Glucose; Chemokine CCL2; Cholesterol; Diabetes Mellitus, Type 2; Disease Models, Animal; DNA Primers; Glucose Tolerance Test; Hydroxymethylglutaryl CoA Reductases; Immunohistochemistry; Insulin; Leptin; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Pravastatin; Rats; Rats, Inbred OLETF; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transforming Growth Factor beta; Transforming Growth Factor beta1; Triglycerides; Tumor Necrosis Factor-alpha; Ventricular Remodeling

2004
Effect of pravastatin on left ventricular mass by activation of myocardial K ATP channels in hypercholesterolemic rabbits.
    Atherosclerosis, 2004, Volume: 176, Issue:2

    Topics: Adenosine Triphosphate; Animals; Anticholesteremic Agents; Disease Models, Animal; Heart; Hypercholesterolemia; Hypertrophy, Left Ventricular; Male; Potassium Channels; Pravastatin; Rabbits

2004
Eisai hyperbilirubinemic rat (EHBR) as an animal model affording high drug-exposure in toxicity studies on organic anions.
    Drug metabolism and pharmacokinetics, 2004, Volume: 19, Issue:5

    Topics: Animals; Anions; Area Under Curve; ATP-Binding Cassette Transporters; Blood Proteins; Creatine Kinase; Disease Models, Animal; Folic Acid Antagonists; Half-Life; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperbilirubinemia; Male; Methotrexate; Muscle, Skeletal; Pravastatin; Protein Binding; Rats; Rats, Inbred Strains; Toxicity Tests; Weight Gain

2004
Pravastatin modulates early diabetic nephropathy in an experimental model of diabetic renal disease.
    The Journal of surgical research, 2005, Volume: 123, Issue:2

    Topics: Animals; Blood Glucose; Body Weight; Cholesterol; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Models, Animal; Glomerular Filtration Rate; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Pravastatin; Proteinuria; Rats; Rats, Sprague-Dawley; Renal Circulation; Renal Insufficiency; Triglycerides; Urine

2005
Combined effects of losartan and pravastatin on interstitial inflammation and fibrosis in chronic cyclosporine-induced nephropathy.
    Transplantation, 2005, Jun-15, Volume: 79, Issue:11

    Topics: Animals; C-Reactive Protein; Cyclosporine; Disease Models, Animal; Fibrosis; Inflammation; Kidney; Kidney Diseases; Losartan; Male; Pravastatin; Rats; Rats, Sprague-Dawley

2005
A novel nitric oxide-releasing statin derivative exerts an antiplatelet/antithrombotic activity and inhibits tissue factor expression.
    Journal of thrombosis and haemostasis : JTH, 2005, Volume: 3, Issue:11

    Topics: Animals; Blood Platelets; Disease Models, Animal; Dose-Response Relationship, Drug; Humans; In Vitro Techniques; Inhibitory Concentration 50; Leukocytes, Mononuclear; Macrophages, Peritoneal; Male; Mice; Nitrates; Nitric Oxide; Nitric Oxide Donors; Nitrites; Nitro Compounds; P-Selectin; Platelet Adhesiveness; Platelet Aggregation; Pravastatin; Pulmonary Embolism; RNA, Messenger; Spleen; Thromboplastin

2005
Hydrophilic statin suppresses vein graft intimal hyperplasia via endothelial cell-tropic Rho-kinase inhibition.
    Journal of vascular surgery, 2005, Volume: 42, Issue:4

    Topics: Animals; Biopsy, Needle; Cell Proliferation; Disease Models, Animal; Graft Rejection; Graft Survival; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperplasia; Immunohistochemistry; In Situ Nick-End Labeling; In Vitro Techniques; Intracellular Signaling Peptides and Proteins; Jugular Veins; Male; Pravastatin; Preoperative Care; Probability; Protein Serine-Threonine Kinases; Rabbits; Random Allocation; Reference Values; rho-Associated Kinases; Risk Factors; Sensitivity and Specificity; Tunica Intima; Vascular Surgical Procedures

2005
Improving effect of ethyl eicosapentanoate on statin-induced rhabdomyolysis in Eisai hyperbilirubinemic rats.
    Biochemical and biophysical research communications, 2006, Feb-03, Volume: 340, Issue:1

    Topics: Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Combinations; Eicosapentaenoic Acid; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperbilirubinemia; Muscle, Skeletal; Platelet Aggregation Inhibitors; Pravastatin; Rats; Rhabdomyolysis; Severity of Illness Index; Treatment Outcome

2006
[The effects of pravastatin on platelet-derived nitric oxide system in rabbits].
    Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2005, Volume: 26, Issue:9

    Topics: Animals; Atherosclerosis; Blood Platelets; Disease Models, Animal; Male; Nitric Oxide; Nitric Oxide Synthase; Pravastatin; Rabbits; RNA, Messenger

2005
[Therapeutic effects of pravastatin on colitis induced by acetic acid and relevant mechanism: experiment with rats].
    Zhonghua yi xue za zhi, 2006, May-16, Volume: 86, Issue:18

    Topics: Acetic Acid; Animals; Colitis, Ulcerative; Colon; Disease Models, Animal; Male; Malondialdehyde; Nitric Oxide; Pravastatin; Rats; Rats, Sprague-Dawley; Superoxide Dismutase

2006
Pravastatin reduces microvascular basal lamina damage following focal cerebral ischemia and reperfusion.
    The European journal of neuroscience, 2006, Volume: 24, Issue:2

    Topics: Animals; Basement Membrane; Biomarkers; Blood-Brain Barrier; Cerebral Arterial Diseases; Cerebral Arteries; Cerebral Infarction; Collagen Type IV; Disease Models, Animal; Down-Regulation; Hemoglobins; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperemia; Ischemic Attack, Transient; Male; Microcirculation; Pravastatin; Rats; Rats, Wistar; Reperfusion Injury

2006
Pravastatin prevents ischemia-reperfusion injury in rat sciatic nerve.
    Surgical neurology, 2006, Volume: 66, Issue:3

    Topics: Animals; Axons; Cytoprotection; Disease Models, Animal; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Inflammation Mediators; Male; Neuroprotective Agents; Oxidative Stress; Peripheral Nerves; Pravastatin; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Sciatic Neuropathy; Time Factors; Treatment Outcome; Wallerian Degeneration

2006
Pravastatin reverses the down-regulating effect of inflammation on beta-adrenergic receptors: a disease-drug interaction between inflammation, pravastatin, and propranolol.
    Vascular pharmacology, 2007, Volume: 46, Issue:1

    Topics: Adrenergic beta-Antagonists; Animals; Anti-Inflammatory Agents; Biological Availability; C-Reactive Protein; Disease Models, Animal; Down-Regulation; Drug Interactions; Electrocardiography; Heart Conduction System; Heart Rate; Inflammation; Interferon-gamma; Interleukin-10; Male; Mycobacterium; Nitrites; Pravastatin; Propranolol; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta; Time Factors

2007
Effects of pravastatin in murine collagen-induced arthritis.
    Rheumatology international, 2007, Volume: 27, Issue:7

    Topics: Animals; Arthritis, Experimental; Aspartate Aminotransferases; Blood Urea Nitrogen; Chemokine CCL2; Chemokines; Collagen Type II; Corticosterone; Creatine Kinase; Creatinine; Disease Models, Animal; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Leukocytes, Mononuclear; Male; Mice; Mice, Inbred DBA; Pravastatin; RNA, Messenger; Synovial Membrane

2007
Pravastatin enhances beneficial effects of olmesartan on vascular injury of salt-sensitive hypertensive rats, via pleiotropic effects.
    Arteriosclerosis, thrombosis, and vascular biology, 2007, Volume: 27, Issue:3

    Topics: Animals; Disease Models, Animal; Drug Interactions; Drug Therapy, Combination; Endothelium, Vascular; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Imidazoles; Nitric Oxide; Oxidation-Reduction; Oxidative Stress; Pravastatin; Rats; Rats, Inbred Dahl; Reference Values; Risk Factors; Sensitivity and Specificity; Sodium Chloride, Dietary; Tetrazoles; Vascular Diseases

2007
Differential impact of atorvastatin vs pravastatin on progressive insulin resistance and left ventricular diastolic dysfunction in a rat model of type II diabetes.
    Circulation journal : official journal of the Japanese Circulation Society, 2007, Volume: 71, Issue:1

    Topics: Adiponectin; Adipose Tissue; Animals; Anticholesteremic Agents; Atorvastatin; Chemokine CCL2; Diabetes Mellitus, Type 2; Disease Models, Animal; Gene Expression Regulation; Glucose; Heptanoic Acids; Hypertriglyceridemia; Insulin Resistance; Leptin; Myocardium; Nitric Oxide; Nitric Oxide Synthase Type III; Pravastatin; Pyrroles; Rats; Rats, Long-Evans; Rats, Mutant Strains; RNA, Messenger; Transforming Growth Factor beta1; Ventricular Dysfunction, Left

2007
Comparison of the antiatherosclerotic effects of dihydropyridine calcium channel blocker and HMG-CoA reductase inhibitor on hypercholesterolemic rabbits.
    Vascular pharmacology, 2007, Volume: 46, Issue:4

    Topics: Animals; Aorta, Thoracic; Atherosclerosis; Calcium Channel Blockers; Cholesterol; Dihydropyridines; Disease Models, Animal; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hyperplasia; Male; Pravastatin; Rabbits; RNA, Messenger; Scavenger Receptors, Class E; Time Factors; Tunica Intima; Up-Regulation; Vascular Cell Adhesion Molecule-1; Vasodilation

2007
Effect of pravastatin on the development of diabetes and adiponectin production.
    Atherosclerosis, 2008, Volume: 196, Issue:1

    Topics: Adipocytes; Adiponectin; Animals; Diabetes Mellitus; Disease Models, Animal; Glucose; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Mice; Obesity; Pravastatin

2008
Anti-inflammatory effects of pravastatin on Helicobacter pylori-induced gastritis in mice.
    Digestive diseases and sciences, 2007, Volume: 52, Issue:10

    Topics: Animals; Biomarkers; Disease Models, Animal; Female; Follow-Up Studies; Gastric Mucosa; Gastritis; Gene Expression; Helicobacter Infections; Helicobacter pylori; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunohistochemistry; Interleukin-1beta; Mice; Mice, Inbred C57BL; Nitric Oxide Synthase Type III; Pravastatin; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Treatment Outcome; Tumor Necrosis Factor-alpha

2007
Effects of Pravastatin on neuroprotection and neurogenesis after cerebral ischemia in rats.
    Neuroscience bulletin, 2007, Volume: 23, Issue:4

    Topics: Animals; Brain Ischemia; Bromodeoxyuridine; Cell Count; Cell Proliferation; Disease Models, Animal; Doublecortin Domain Proteins; Doublecortin Protein; Male; Microtubule-Associated Proteins; Neurologic Examination; Neurons; Neuropeptides; Neuroprotective Agents; Phosphopyruvate Hydratase; Pravastatin; Rats; Rats, Wistar; Time Factors

2007
Effect of pravastatin on sympathetic reinnervation in postinfarcted rats.
    American journal of physiology. Heart and circulatory physiology, 2007, Volume: 293, Issue:6

    Topics: Animals; Blotting, Western; Cardiac Pacing, Artificial; Coronary Vessels; Disease Models, Animal; GAP-43 Protein; Glyburide; Heart; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunohistochemistry; KATP Channels; Ligation; Male; Myocardial Infarction; Myocardium; Neurofilament Proteins; Nicorandil; Norepinephrine; Pinacidil; Polymerase Chain Reaction; Potassium Channel Blockers; Pravastatin; Rats; Rats, Wistar; RNA, Messenger; Sympathetic Nervous System; Tachycardia, Ventricular; Time Factors; Tyrosine 3-Monooxygenase; Ventricular Fibrillation; Ventricular Remodeling

2007
Pravastatin reduces myocardial infarct size via increasing protein kinase C-dependent nitric oxide, decreasing oxyradicals and opening the mitochondrial adenosine triphosphate-sensitive potassium channels in rabbits.
    Circulation journal : official journal of the Japanese Circulation Society, 2007, Volume: 71, Issue:10

    Topics: Animals; Blood Pressure; Disease Models, Animal; Dose-Response Relationship, Drug; Heart Rate; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ischemic Preconditioning, Myocardial; KATP Channels; Male; Mitochondria, Heart; Myocardial Infarction; Nitric Oxide; Pravastatin; Protein Kinase C; Rabbits; Reactive Oxygen Species; Superoxides

2007
Statin reverses reduction of adiponectin receptor expression in infarcted heart and in TNF-alpha-treated cardiomyocytes in association with improved glucose uptake.
    American journal of physiology. Heart and circulatory physiology, 2007, Volume: 293, Issue:6

    Topics: Acetylcysteine; Adiponectin; Administration, Oral; Animals; Animals, Newborn; Antioxidants; Blood Glucose; Cells, Cultured; Coronary Vessels; Disease Models, Animal; Dose-Response Relationship, Drug; Fatty Acids; Glucose; Hydrogen Peroxide; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Insulin; Insulin Resistance; Ligation; Lipids; Male; Mice; Myocardial Infarction; Myocardium; Myocytes, Cardiac; Oxidation-Reduction; Pravastatin; Rats; Rats, Sprague-Dawley; Receptors, Adiponectin; Recombinant Proteins; RNA Interference; RNA, Messenger; RNA, Small Interfering; Time Factors; Tumor Necrosis Factor-alpha

2007
Postischemic administration of HMG CoA reductase inhibitor inhibits infarct expansion after transient middle cerebral artery occlusion.
    Brain research, 2007, Nov-21, Volume: 1181

    Topics: Animals; Brain; Brain Ischemia; Disease Models, Animal; Drug Administration Schedule; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Infarction, Middle Cerebral Artery; Male; Pravastatin; Rats; Rats, Wistar

2007
A comparison between the effects of hydrophobic and hydrophilic statins on osteoclast function in vitro and ovariectomy-induced bone loss in vivo.
    Calcified tissue international, 2007, Volume: 81, Issue:5

    Topics: Anabolic Agents; Animals; Animals, Newborn; Bone and Bones; Bone Resorption; Cells, Cultured; Disease Models, Animal; Female; Hydrophobic and Hydrophilic Interactions; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mice; Mice, Inbred BALB C; Osteoclasts; Osteoporosis; Ovariectomy; Pravastatin; Protein Prenylation; Pyridines; Rabbits; rap1 GTP-Binding Proteins; Signal Transduction; Simvastatin; Water

2007
Down-regulation of intestinal multidrug resistance-associated protein 2 in long-evans cinnamon rats.
    Drug metabolism and pharmacokinetics, 2007, Volume: 22, Issue:6

    Topics: Animals; ATP-Binding Cassette Transporters; Disease Models, Animal; Down-Regulation; Hepatolenticular Degeneration; Jejunum; Male; Mannitol; Pravastatin; Probenecid; Rats; Rats, Inbred LEC; Rats, Wistar; RNA, Messenger; Species Specificity; Sulfobromophthalein

2007
Pravastatin attenuates left ventricular remodeling and diastolic dysfunction in angiotensin II-induced hypertensive mice.
    Journal of cardiovascular pharmacology, 2008, Volume: 51, Issue:1

    Topics: Angiotensin II; Animals; Blood Pressure; Cholesterol; Disease Models, Animal; Fibrosis; Gene Expression Regulation; Heart Failure, Diastolic; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Hypertrophy, Left Ventricular; Male; Mice; Mice, Inbred C57BL; Pravastatin; rho-Associated Kinases; Ventricular Remodeling

2008
Regulation of apolipoprotein B secretion in hepatocytes from Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia.
    Atherosclerosis, 1995, Apr-07, Volume: 114, Issue:1

    Topics: Animals; Apolipoproteins B; Cells, Cultured; Cholesterol Esters; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Female; Hyperlipoproteinemia Type II; Lipoproteins, LDL; Liver; Male; Pravastatin; Rabbits; Receptors, LDL

1995
The mechanism of comparable serum cholesterol lowering effects of pravastatin sodium, a 3-hydroxy-3-methylglutaryl coenzyme A inhibitor, between once- and twice-daily treatment regimens in beagle dogs and rabbits.
    Japanese journal of pharmacology, 1996, Volume: 70, Issue:4

    Topics: Administration, Oral; Animals; Antibodies, Monoclonal; Anticholesteremic Agents; Binding, Competitive; Cells, Cultured; Cholesterol; Disease Models, Animal; Dogs; Drug Administration Schedule; Enzyme Inhibitors; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunoblotting; Iodine Radioisotopes; Isotope Labeling; Liver; Male; Pravastatin; Rabbits; Receptors, LDL; Species Specificity; Up-Regulation

1996
Effects of chronic combined treatment with captopril and pravastatin on the progression of insulin resistance and cardiovascular alterations in an experimental model of obesity in dogs.
    American journal of hypertension, 1998, Volume: 11, Issue:7

    Topics: Animals; Anticholesteremic Agents; Antihypertensive Agents; Blood Glucose; Blood Pressure; Body Weight; Captopril; Cardiovascular Diseases; Cholesterol; Coronary Vessels; Disease Models, Animal; Disease Progression; Dogs; Drug Therapy, Combination; Heart; Insulin; Insulin Resistance; Linear Models; Male; Multivariate Analysis; Myocardium; Obesity; Pravastatin; Triglycerides

1998
Atherosclerosis in Marek's disease virus infected hypercholesterolemic roosters is reduced by HMGCoA reductase and ACE inhibitor therapy.
    Cardiovascular research, 1998, Volume: 38, Issue:1

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Arteriosclerosis; Carotid Arteries; Chickens; Cholesterol; Disease Models, Animal; Herpesvirus 2, Gallid; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Isoquinolines; Lymphocytes; Marek Disease; Pravastatin; Quinapril; Tetrahydroisoquinolines

1998
Combination treatment with troglitazone, an insulin action enhancer, and pravastatin, an inhibitor of HMG-CoA reductase, shows a synergistic effect on atherosclerosis of WHHL rabbits.
    Atherosclerosis, 1999, Volume: 142, Issue:2

    Topics: Animals; Aorta, Thoracic; Arteriosclerosis; Blood Glucose; Cholesterol, LDL; Chromans; Coronary Vessels; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Female; Glucose Tolerance Test; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperinsulinism; Hyperlipoproteinemia Type II; Hypoglycemic Agents; Insulin Resistance; Male; Pravastatin; Rabbits; Thiazoles; Thiazolidinediones; Troglitazone; Xanthomatosis

1999
Pravastatin restored the infarct size-limiting effect of ischemic preconditioning blunted by hypercholesterolemia in the rabbit model of myocardial infarction.
    Journal of the American College of Cardiology, 1999, Volume: 34, Issue:7

    Topics: 5'-Nucleotidase; Animals; Cholesterol; Cholesterol, Dietary; Disease Models, Animal; Heart Ventricles; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Ischemic Preconditioning, Myocardial; Myocardial Infarction; Pravastatin; Rabbits; Treatment Outcome; Triglycerides

1999
Effects of lovastatin and pravastatin on the survival of hamsters with inherited cardiomyopathy.
    Journal of cardiovascular pharmacology and therapeutics, 2000, Volume: 5, Issue:4

    Topics: Administration, Oral; Animals; Anticholesteremic Agents; Cardiomyopathies; Cricetinae; Disease Models, Animal; Female; Lovastatin; Male; Pravastatin; Sex Factors; Survival Analysis; Ubiquinone

2000
Fluvastatin suppresses oxidative stress and fibrosis in the interstitium of mouse kidneys with unilateral ureteral obstruction.
    Kidney international, 2001, Volume: 59, Issue:6

    Topics: Actins; Animals; Cholesterol; Disease Models, Animal; Fatty Acids, Monounsaturated; Fibrosis; Fluvastatin; Gene Expression; Glycation End Products, Advanced; Heme Oxygenase (Decyclizing); Heme Oxygenase-1; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Kidney; Membrane Proteins; Mice; Nephritis, Interstitial; Oxidative Stress; Pravastatin; RNA, Messenger; Triglycerides; Ureteral Obstruction

2001
Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site.
    Nature medicine, 2001, Volume: 7, Issue:6

    Topics: Allosteric Site; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Adhesion; Disease Models, Animal; Drug Design; Humans; Integrin alpha4beta1; Integrins; Intercellular Adhesion Molecule-1; Lovastatin; Lymphocyte Activation; Lymphocyte Function-Associated Antigen-1; Macrophage-1 Antigen; Mice; Models, Molecular; Molecular Structure; Mutagenesis, Site-Directed; Naphthalenes; Peritonitis; Pravastatin; Protein Binding; Receptors, Lymphocyte Homing; T-Lymphocytes

2001
Pravastatin reduces myocardial lesions induced by acute inhibition of nitric oxide biosynthesis in normocholesterolemic rats.
    International journal of cardiology, 2001, Volume: 79, Issue:2-3

    Topics: Analysis of Variance; Animals; Anticholesteremic Agents; Cardiomyopathies; Disease Models, Animal; Endothelium, Vascular; Enzyme Inhibitors; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Necrosis; NG-Nitroarginine Methyl Ester; Nitrates; Nitric Oxide Synthase; Nitrites; Pravastatin; Rats; Rats, Wistar; Thromboxane B2

2001
Antiinflammatory and antiarteriosclerotic actions of HMG-CoA reductase inhibitors in a rat model of chronic inhibition of nitric oxide synthesis.
    Circulation research, 2001, Aug-31, Volume: 89, Issue:5

    Topics: Animals; Anti-Inflammatory Agents; Arteriosclerosis; Blood Pressure; Chemokine CCL2; Coronary Vessels; Disease Models, Animal; Dose-Response Relationship, Drug; Gene Expression Regulation; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunohistochemistry; Lipids; Macrophages; Male; Monocytes; NG-Nitroarginine Methyl Ester; Nitrates; Nitric Oxide Synthase; Nitrites; Nitroarginine; Peptidyl-Dipeptidase A; Pravastatin; Proliferating Cell Nuclear Antigen; Pyridines; Rats; Rats, Inbred WKY; rhoA GTP-Binding Protein; RNA, Messenger; Systole; Transforming Growth Factor beta; Transforming Growth Factor beta1

2001
Stability of atheromatous plaque affected by lesional composition: study of WHHL rabbits treated with statins.
    Annals of the New York Academy of Sciences, 2001, Volume: 947

    Topics: Animals; Anticholesteremic Agents; Arteriosclerosis; Disease Models, Animal; Fatty Acids, Monounsaturated; Fluvastatin; Indoles; Lipids; Pravastatin; Rabbits

2001
Experimental model of escape phenomenon in hamsters and the effectiveness of YM-53601 in the model.
    British journal of pharmacology, 2002, Volume: 135, Issue:6

    Topics: Animals; Anticholesteremic Agents; Cholesterol; Cricetinae; Dietary Fats; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Induction; Enzyme Inhibitors; Farnesyl-Diphosphate Farnesyltransferase; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Mesocricetus; Pravastatin; Quinuclidines

2002
Importance of NAD(P)H oxidase-mediated oxidative stress and contractile type smooth muscle myosin heavy chain SM2 at the early stage of atherosclerosis.
    Circulation, 2002, May-14, Volume: 105, Issue:19

    Topics: Actins; Animals; Anticholesteremic Agents; Antioxidants; Aorta, Thoracic; Arteriosclerosis; Cholesterol; Diet, Atherogenic; Disease Models, Animal; Elasticity; Hypercholesterolemia; Male; Membrane Transport Proteins; Muscle, Smooth, Vascular; Myosin Heavy Chains; NADH, NADPH Oxidoreductases; NADPH Dehydrogenase; NADPH Oxidases; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Oxidative Stress; Phosphoproteins; Pravastatin; Probucol; Protein Isoforms; Rabbits; Smooth Muscle Myosins; Superoxides

2002
Inhibitory effects of pravastatin, a competitive inhibitor of hydroxymethylglutaryl coenzyme A reductase, on cholesterol gallstone formation in prairie dogs.
    Digestion, 1992, Volume: 51, Issue:3

    Topics: Animals; Bile; Bile Acids and Salts; Cholelithiasis; Cholesterol; Cholesterol, Dietary; Disease Models, Animal; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Phospholipids; Pravastatin; Sciuridae

1992
The effect of pravastatin on serum cholesterol levels in hypercholesterolemic diabetic rabbits.
    Biochimica et biophysica acta, 1991, Apr-15, Volume: 1096, Issue:3

    Topics: Animals; Anticholesteremic Agents; Apolipoproteins; Body Weight; Cholesterol; Coconut Oil; Diabetes Complications; Diabetes Mellitus; Diet, Atherogenic; Disease Models, Animal; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Lipoproteins; Male; Naphthalenes; Plant Oils; Pravastatin; Rabbits; Triglycerides

1991
[Effects of a competitive inhibitor of hydroxymethylglutaryl coenzyme A reductase on cholesterol gallstone formation in prairie dogs].
    Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 1991, Volume: 88, Issue:8

    Topics: Animals; Cholelithiasis; Cholesterol; Disease Models, Animal; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Pravastatin; Sciuridae

1991
Lipoproteins and atherosclerosis.
    Japanese circulation journal, 1990, Volume: 54, Issue:9

    Topics: Animals; Anticholesteremic Agents; Arteriosclerosis; Cholesterol; Cholesterol Esters; Cholestyramine Resin; Disease Models, Animal; Foam Cells; Heptanoic Acids; Hyperlipidemia, Familial Combined; Lipoproteins, LDL; Liver; Macrophages; Mice; Naphthalenes; Pravastatin; Probucol; Rabbits; Receptors, Cell Surface; Receptors, Lipoprotein

1990